Publications Print Dronca RS, Jones JC, Maniaci MJ, Elantably D, Mazza GL, Murthy HS, Nolan L, Hunze JL, Fischer DL, Obi CA, Jackson AA, Biddle AM, Confiado SM, Smith N, Michaelides L, Quinones-Hinojosa A, Ridgeway JL, Borah BJ, Dunn AN, Thielen KR, Willman CL. Cancer CARE (Connected Access and Remote Expertise) Beyond Walls - Safety, Feasibility, and Patient Experience of Home-Based Chemotherapy The New England Journal of Medicine. 03/18/2026; 7(4). Epub 2026 Mar 18. Abdelhakeem AA, O'donnell CD, Elantably D, Adeoye O, Babiker HM, Starr J, Yang L, Legout JD, Toskich B, Harnois DM, Jones JC, Croome KP, Majeed U. Transplant Oncology in Evolution: Emerging Roles for Liver Transplant Beyond Hepatocellular Carcinoma. Cancers (Basel). 2026 Mar 10; 18 (6) View PubMed Jamal F, Sahwan O, Abidoye S, Alsulaiman AA, Sheashaa H, Ahn DH, Wu C, Borad M, Zhu M, Jones JC, Halfdanarson TR, Jin Z, Babiker H, Majeed U, Bekaii-Saab T, Starr JS, Yoon H, Sonbol MB. Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal Carcinoma. JCO Precis Oncol. 2026 Mar; 10 (3):e2501194 Epub 2026 Mar 25 View PubMed Sacchi de Camargo Correia G, Hazim AZ, Zheng-Lin B, Gannon N, Boyle AWR, Crowe S, Jones J, Manochakian R. Study of the Perceptions and Concerns of a Single Health System Hematology and Oncology Workforce About Artificial Intelligence in Clinical Practice and Medical Education. JCO Clin Cancer Inform. 2026 Mar; 10:e2500296 Epub 2026 Mar 30 View PubMed Jones J, Taner CB, O'Donnell C, Fischer R, Inabinett S, Boyle A, Majeed U, Bolan C, Toskich B, Merchea A, Yang L, Harnois D, Croome KP. Is there a place for deceased donor liver transplantation for colorectal metastases in the United States? Feasibility of a protocol utilizing machine perfusion. Liver Transpl. 2026 Feb 1; 32 (2):144-152 Epub 2025 Sept 17 View PubMed Gandini A, Probst V, Landi M, De Grandis MC, Cremolini C, Lonardi S, Girot P, Decraecker M, Passardi A, Salvatore L, Pastorino A, Jones JC, Grados L, Sayah L, Trouilloud I, Tougeron D, Taieb J. Switch from cetuximab to panitumumab during encorafenib-based therapy in BRAF V600E mutated metastatic colorectal cancer: An international multicenter analysis from the AGEO group. Clin Res Hepatol Gastroenterol. 2026 Jan; 50 (1):102746 Epub 2025 Dec 16 View PubMed Hoyek C, Pirozzi A, Okano N, Bauernfeind JJ, Jones J, Bekaii-Saab T. Multikinase inhibitors in refractory metastatic colorectal cancer: an optimal sequence? Clin Adv Hematol Oncol. 2026 Jan-Feb; 24 (1):22-28 View PubMed Dasari A, Eng C, Lonardi S, Garcia-Carbonero R, Masuishi T, Cremolini C, Ghiringhelli F, Hubbard J, Bekaii-Saab T, Jones J, Xu RH, Shen L, Xu J, Bai Y, Deng Y, Yuan Y, Wei W, Lin J, Chen L, Yang Z, Schelman WR, Qin S, Li J. Fruquintinib in less pretreated patients: Multivariate profile-matching analysis of FRESCO-2 to FRESCO. Eur J Cancer. 2025 Sep 9; 227:115641 Epub 2025 July 13 View PubMed Mahadevia H, Majeed U, Patel J, Ahmed AK, Elhariri A, Albelal D, Rao NNM, Rachamala HK, Mosalem O, Mukhopadhyay D, Jones J, Mahadevan D, Borad MJ, Ahn D, Sonbol MB, Tran N, Mahipal A, Wee Ma W, McWilliams RR, Halfdanarson TR, Kankeu Fonkoua LA, Bekaii-Saab T, Mody K, Babiker H. Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors. JAMA Netw Open. 2025 Sep 2; 8 (9):e2531373 Epub 2025 Sept 02 View PubMed Elhariri A, Patel J, Mahadevia H, Modi K, Albelal D, Majeed U, Jones JC, Borad MJ, Tran NH, Rutenberg MS, Babiker H. Stereotactic body radiation therapy in oligometastatic pancreatic cancer: overall survival improvement and SMAD4 as a predictor of progression-free survival. J Gastrointest Oncol. 2025 Aug 30; 16 (4):1658-1666 Epub 2025 Aug 26 View PubMed Hoyek C, Zheng-Lin B, Jones J, Bekaii-Saab T. Tucatinib in the treatment of HER2-overexpressing gastrointestinal cancers: current insights and future prospects. Expert Opin Investig Drugs. 2025 Mar; 34 (3):161-168 Epub 2025 Feb 28 View PubMed Hoyek Celine, Pirozzi Angelo, Jones Jeremy, Rimassa Lorenza, Sonbol Mohamad, Bekaii-Saab Tanios. Advances in targeting KRAS G12C in Gastrointestinal malignancies: Focus on KRAS G12C inhibitors. touchREVIEWS in Oncology & Haematology. 2025. Siddiqui W, Pacyna JE, Phelan SM, Jones JC, Samadder NJ, Sharp RR. Factors Impacting Intent to Share Multigenic Cancer Testing Results in a Community Hospital Setting. J Pers Med. 2024 Sep 17; 14 (9) Epub 2024 Sept 17 View PubMed Elhariri A, Patel J, Mahadevia H, Albelal D, Ahmed AK, Jones JC, Borad MJ, Babiker H. Identifying Actionable Alterations in KRAS Wild-Type Pancreatic Cancer. Target Oncol. 2024 Sep; 19 (5):679-689 Epub 2024 Aug 10 View PubMed Saberzadeh-Ardestani B, Jones JC, McWilliams RR, Tougeron D, Halfdanarson TR, Guimbaud R, Hubbard JM, Flecchia C, Shi Q, Alouani E, Sonbol MB, Ticku J, Jin Z, Taieb J, Sinicrope FA. Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting. Eur J Cancer. 2024 Jan; 196:113433 Epub 2023 Nov 10 View PubMed Elhariri A, Alhaj A, Ahn D, Sonbol MB, Bekaii-Saab T, Wu C, Rutenberg MS, Stauffer J, Starr J, Majeed U, Jones J, Borad M, Babiker H. Targeting KRAS in pancreatic adenocarcinoma: Progress in demystifying the holy grail. World J Clin Oncol. 2023 Aug 24; 14 (8):285-296 View PubMed Dasari A, Lonardi S, Garcia-Carbonero R, Elez E, Yoshino T, Sobrero A, Yao J, Garcia-Alfonso P, Kocsis J, Cubillo Gracian A, Sartore-Bianchi A, Satoh T, Randrian V, Tomasek J, Chong G, Paulson AS, Masuishi T, Jones J, Csoszi T, Cremolini C, Ghiringhelli F, Shergill A, Hochster HS, Krauss J, Bassam A, Ducreux M, Elme A, Faugeras L, Kasper S, Van Cutsem E, Arnold D, Nanda S, Yang Z, Schelman WR, Kania M, Tabernero J, Eng C, FRESCO-2 Study Investigators. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. Lancet. 2023 Jul 1; 402 (10395):41-53 Epub 2023 June 15 View PubMed Jones JC, Golafshar MA, Coston TW, Rao R, Wysokinska E, Johnson E, Esplin ED, Nussbaum RL, Heald B, Klint M, Barrus K, Uson PL Jr, Nguyen CC, Colon-Otero G, Bekaii-Saab TS, Dronca R, Kunze KL, Samadder NJ. Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program. Cureus. 2023 Apr; 15 (4):e37428 Epub 2023 Apr 11 View PubMed Saberzadeh-Ardestani B, Jones JC, Hubbard JM, McWilliams RR, Halfdanarson TR, Shi Q, Sonbol MB, Ticku J, Jin Z, Sinicrope FA. Association Between Survival and Metastatic Site in Mismatch Repair-Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab. JAMA Netw Open. 2023 Feb 1; 6 (2):e230400 Epub 2023 Feb 01 View PubMed Sonbol MB, Siddiqi R, Uson PLS, Pathak S, Firwana B, Botrus G, Almader-Douglas D, Ahn DH, Borad MJ, Starr J, Jones J, Stucky CC, Smoot R, Riaz IB, Bekaii-Saab T. The Role of Systemic Therapy in Resectable Colorectal Liver Metastases: Systematic Review and Network Meta-Analysis. Oncologist. 2022 Dec 9; 27 (12):1034-1040 View PubMed Raoof M, Sullivan KM, Frankel PH, Fakih M, Synold TW, Lim D, Woo Y, Paz IB, Fong Y, Thomas RM, Chang S, Eng M, Tinsley R, Whelan RL, Deperalta D, Reymond MA, Jones J, Merchea A, Dellinger TH. Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: rationale and design. Pleura Peritoneum. 2022 Dec; 7 (4):169-177 Epub 2022 June 21 View PubMed Rutenberg MS, Hoppe BS, Starr JS, Awad Z, Thomas M, Morris CG, Johnson P, Henderson RH, Jones JC, Gharia B, Bowers S, Wolfsen HC, Krishnan S, Ko SJ, Babiker HM, Nichols RC Jr. Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes. Int J Part Ther. 2023 Winter; 9 (3):18-29 Epub 2022 Dec 19 View PubMed Sardar M, Recio-Boiles A, Mody K, Karime C, Chandana SR, Mahadevan D, Starr J, Jones J, Borad M, Babiker H. Pharmacotherapeutic options for pancreatic ductal adenocarcinoma. Expert Opin Pharmacother. 2022 Dec; 23 (18):2079-2089 Epub 2022 Nov 28 View PubMed Ueberroth BE, Jones JC, Bekaii-Saab TS. Circulating tumor DNA (ctDNA) to evaluate minimal residual disease (MRD), treatment response, and posttreatment prognosis in pancreatic adenocarcinoma. Pancreatology. 2022 Sep; 22 (6):741-748 Epub 2022 June 12 View PubMed Ueberroth BE, Jones JC, Bekaii-Saab T. The role of circulating tumor DNA in evaluating minimal residual disease in luminal gastrointestinal malignancies. Clin Adv Hematol Oncol. 2022 Jul; 20 (7):444-455 View PubMed Uson Junior PLS, Majeed U, Yin J, Botrus G, Sonbol MB, Ahn DH, Starr JS, Jones JC, Babiker H, Inabinett SR, Wylie N, Boyle AWR, Bekaii-Saab TS, Gores GJ, Smoot R, Barrett M, Nagalo B, Meurice N, Elliott N, Petit J, Zhou Y, Arora M, Dumbauld C, Barro O, Baker A, Bogenberger J, Buetow K, Mansfield A, Mody K, Borad MJ. Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy. JCO Precis Oncol. 2022 Jun; 6 (1):e2100274 View PubMed Uson PLS Jr, Riegert-Johnson D, Boardman L, Kisiel J, Mountjoy L, Patel N, Lizaola-Mayo B, Borad MJ, Ahn D, Sonbol MB, Jones J, Leighton JA, Gurudu S, Singh H, Klint M, Kunze KL, Golafshar MA, Esplin ED, Nussbaum RL, Stewart AK, Bekaii-Saab TS, Jewel Samadder N. Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study. Clin Gastroenterol Hepatol. 2022 Mar; 20 (3):e508-e528 Epub 2021 Apr 20 View PubMed Broccard SP, Kasbi AA, Bagaria SP, Jones J, Shoudry M, Gabriel EM. Liquid biopsies for colorectal cancer: a narrative review of ongoing clinical trials and the current use of this technology at a comprehensive cancer center. J Gastrointest Oncol. 2022 Feb; 13(1):438-449. View PubMed Gupta K, Jones JC, Farias VA, Mackeyev Y, Singh PK, Quiñones-Hinojosa A, Krishnan S. Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma. Front Oncol. 2022; 12:840241. Epub 2022 May 18. View PubMed Jones J, Ciombor K, Wu C, Bekaii-Saab T, Strickler J. Addressing Resistance to Targeted Therapies in Metastatic Colorectal Cancer. Oncology (Williston Park). 2021 Oct 21; 35 (10):654-660 View PubMed Ciombor K, Jones J, Strickler J, Bekaii-Saab T, Wu C. The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform. Oncology (Williston Park). 2021 Sep 15; 35 (9):553-559 Epub 2021 Sept 15 View PubMed Alhaj Moustafa M, Jiang L, Kuhlman JJ, Jones J, Lou Y, Sokumbi O, Tun HW. BRAF p.V600E associated poly-neoplastic syndrome. Rare Tumors. 2021; 13:20363613211012929 Epub 2021 Apr 27 View PubMed Wang Y, Jones JC, Jones JC, Kipp BR, Grothey A. Activity of EGFR antibody in non-V600 BRAF mutant metastatic colorectal cancer. Ann Oncol 2019 Jan 1; 30 (1):147-149 View PubMed Jones JC, Renfro LA, Al-Shamsi HO, Schrock AB, Rankin A, Zhang BY, Kasi PM, Voss JS, Leal AD, Sun J, Ross J, Ali SM, Hubbard JM, Kipp BR, McWilliams RR, Kopetz S, Wolff RA, Grothey A. (Non-V600) BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer. J Clin Oncol. 2017 Aug 10; 35 (23):2624-2630 Epub 2017 May 09 View PubMed Zhang BY, Jones JC, Briggler AM, Hubbard JM, Kipp BR, Sargent DJ, Dixon JG, Grothey A. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2017 Jun; 16 (2):124-128 Epub 2016 Sept 17 View PubMed Al-Shamsi HO, Jones J, Jones J, Fahmawi Y, Dahbour I, Tabash A, Abdel-Wahab R, Abousamra AO, Shaw KR, Xiao L, Hassan MM, Kipp BR, Kopetz S, Soliman AS, McWilliams RR, Wolff RA. Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern. J Gastrointest Oncol. 2016 Dec; 7 (6):882-902 View PubMed Salahudeen AA, Gupta A, Jones JC, Cowan RW, Vusirikala M, Kwong C, Naina HV. PTHrP-Induced Refractory Malignant Hypercalcemia in a Patient With Chronic Lymphocytic Leukemia Responding to Denosumab. Clin Lymphoma Myeloma Leuk. 2015 Sep; 15 (9):e137-40 Epub 2015 June 19 View PubMed Jones J, Gupta A, Naina H. Primary dural lymphoma: Complete remission after treatment with radiation therapy. Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jun 22; 32 (1):80-2 Epub 2015 June 22 View PubMed Jones JC, Chokshi S, Pistenmaa D, Naina HV. Primary cutaneous follicle center lymphoma arising adjacent to silicone breast implant. Clin Breast Cancer. 2014 Apr; 14 (2):e65-7 Epub 2013 Oct 25 View PubMed PST-20469881 Home Publications